Efficacy and Safety of KI1001 in ≥ 55 Years Old Insomnia Patients

NCT01450228 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

DRUG: KI1001
DRUG: Placebo KI1001

Sponsor

Kuhnil Pharmaceutical Co., Ltd.

Collaborators

[object Object]